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   A case of a giant vesical stone containing 2， 8－dihydroxyadenine was presented．
   The patient wa＄．．2． 4－ye． ar－o．ld．rn． an whQ had frequently pas．sed small stones with dysuria since age
of 8 years． In Septbmber l．9ブ2， with dysμr三a， high fever and genera工fatigue， he was admitted to N三shi－
nomiya Prefectural Hospital． Uric acid levels in serum and urine were 10．6 mgfdl and 13 rngfday
respectively， and there were also significant rises of serum creatinine and BUN levels， so that he was
diagnosed to be already in uremic stage． X ray examinations showed a giant vesical stone and stag－
horn calculus in the left 1〈idney． On september 8， 1972， cystolithotomy was performed uneventfully．
    The removed vesical stone was 5．0×4．2×4．O cm in size and 100 g in weight， and analysis by
infrared spectroscopy showed a mixture of struvite and a purine compound． Neither uric acid， urate
nor xanthine was contained．
   In March 1973， there were ’further rises of serum creatinine and BUN levels， therefore he was
advised to be controled by hemodialysis． Since this time， he stopped to visit Nishinomiya Prefectural
Hospital．
   Six years later， the removed vesical stone was more precisely analyzed again by infrared spectros－
copy． This study showed a mixture of struvite or newberyite and 2， 8－dihydroxyadenine．































RBC 278×104／mm3， Hb 92 g／dl， Ht 28％， WBC




        Fig．2． KUB
淡いX線不透過性を示す巨大な膀胱結石を認める．
7800／mm3．血液化学；Na l 31 mEq／L， K 5．1mEq／L，
Cl lOO mEq／L， BUN 66 mg／dl，クレアチニン11．4 mg
／dl， Ca 8．8 mg／d1， Pi 7．O mgfdl，尿酸10．6 mg／dL肝
機能；total protein 8．49／dl， A／G 1．4，黄疽指数3，
GPT l 7u， GOT 34u，アルカリフォスファターゼ11．O
K。A． u． PSP排泄試験；15，30，60分値いずれもにO％，
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     H H  i－i2，8－Dihydroxyadenine Uric acid
      Van Acker， K J、 et al，：New En国．J． Med．，297：t27， t 977．よcJ改変
Fig．7 ヒトにおけるアデニン化合物の主な代謝経路，
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